PubMed · 2010 · 12 citations · 0 references
Life SciencesGeneticsImmunologyImmunogeneticsStem Cell TransplantationTransplant ImmunologyAllogeneic Stem Cell TransplantationCytokine Gene PolymorphismGraft-versus-host DiseaseHistocompatibilityMajor Histocompatibility ComplexTransplantation ImmunogeneticsAllogeneic Stem Cell TherapyGraft-versus-host Disease BiomarkersGraft-versus-host Disease ImmunogeneticsGraft-versus-host Disease PathophysiologyHematopoietic Stem Cell Transplantation ImmunogeneticsInflammatory Gene PolymorphismsInterleukin-6 Gene PolymorphismsTransplant Immunogenomics
OBJECTIVES: Analysis of nonhistocompatibility leucocyte antigen functional genomics in stem cell transplant can lead to prediction of clinical outcomes in histocompatibility leucocyte antigen-matched sibling-transplant recipients. Some of the cytokine gene polymorphisms might be associated with severe, acute graft-versus-host disease after allogeneic stem cell transplant. We evaluated gene polymorphisms of IL-6 G-174C, TGF-beta T+869C, IL-4 C-590T, and IFN-alpha T+874A cytokines in bone marrow transplant patients. MATERIALS AND METHODS: The amplification refractory mutation system-polymerase chain reaction ARMSPCR method was used to characterize IL-6 G-174C, TGF-beta T+869C, and IFN-alpha T+874A polymorphisms, and PCR-RFLP, using AvaII restriction enzyme, was done for IL-4 C-590T characterization in 35 bone marrow transplant patients. Acute graft-versus-host disease episodes were diagnosed according to EMBT criteria. RESULTS: Analysis showed that IFN-alpha +874T allele (P = .027, OR=0.198, 95% CI=0.049-0.801) was correlated to moderate-to-severe graft-versus-host disease. TGF-beta T+869C, IFN-alpha T+874A, IL-6 G-174C and IL-4 C-590T frequencies were not significantly different in the 2 graft-versus-host disease severity groups (P > .05). CONCLUSIONS: According to the results, we concluded that the IFN-alpha T+874A gene polymorphism has a predictive value for severity of graft-versus-host disease after bone marrow transplant. High producer genotypes of IFN-alpha are genetic risk factors for development of graft-versus-host disease.